Cart
sales@molnova.com
VER-49009 (b)
CAS No. 940289-57-6
VER-49009 (b)( —— )
Catalog No. M17677 CAS No. 940289-57-6
VER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 69 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 267 | In Stock |
|
| 50MG | 447 | In Stock |
|
| 100MG | 609 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVER-49009 (b)
-
NoteResearch use only, not for human use.
-
Brief DescriptionVER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).
-
DescriptionVER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCCR
-
RecptorHSP90β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number940289-57-6
-
Formula Weight387.82
-
Molecular FormulaC19H18ClN3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1(c(cc(c(c1)c1c(c([nH]n1)C(=O)NCC)c1ccc(cc1)OC)O)O)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sharp SY, et al. Mol Y Ther. 2007, 6(4), 1198-1211.
molnova catalog
related products
-
Plozalizumab
Plozalizumab (MLN-1202) is a humanized, selective, and potent anti-CCR2 antibody with antitumor activity, used in the study of malignant melanoma.
-
J-113863
J-113863 is also a potent antagonist of the human CCR3 (IC50 of 0.58 nM) , but a weak antagonist of the mouse CCR3 (IC50 of 460 nM). J-113863 is inactive against CCR2, CCR4 and CCR5, as well as the LTB4 or TNF-α receptors. Anti-inflammatory effect. J-113863 is a potent and selective CCR1 (CD18) antagonist with IC50 values of 0.9 nM and 5.8?nM for human and mouse CCR1 receptors, respectively.
-
SB 328437
SB 328437 is an effective and selective antagonist of CCR3 (IC50 = 4.5 nM).
